Repros Therapeutics Q2 Loss Widens

(RTTNews) - Repros Therapeutics Inc. (RPRX) Monday said second-quarter loss widened to $8.7 million from $7.2 million in the comparable quarter last year. Loss per share for the latest second quarter was $0.38, same as last year.

On average, six analysts polled by Thomson Reuters expected the company to report a loss of $0.39 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues and other income increased to $2 thousand from $1 thousand last year.

Research and development expenses increased 23 percent to $7.5 million from $6.0 million in the year-ago period, while general and administrative totaled $1.3 million, up 7 percent from $1.2 million.